Fate Therapeutics (FATE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FATE | SABS | IMRX | ||
| Company | Fate Therapeutics | Sab Biotherapeutics Inc | Immuneering Corp Cl A | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.53 | 3.86 | 4.53 | ||
| High | 2.88 | 3.95 | 4.57 | ||
| Low | 2.48 | 3.85 | 4.43 | ||
| Last | 2.80 | 3.90 | 4.51 | ||
| Change | +0.31 | +0.05 | +0.05 | ||
| Percent Change | +12.45% | +1.30% | +1.12% | ||
| Volume | 4,015,500 | 343,900 | 723,200 | ||
| 20-Day Average Volume | 2,374,935 | 498,310 | 711,955 | ||
| Previous | 2.49 | 3.85 | 4.46 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.63 | 3.63 | 4.49 | ||
| 20-Day Raw Stochastic | 56.12% | 88.71% | 39.51% | ||
| 20-Day Relative Strength | 57.17 | 56.65 | 48.28 | ||
| Weighted Alpha | +106.69 | +58.07 | +14.90 | ||
| Today's Opinion | 100% Buy | 8% Sell | 88% Sell | ||
| Yesterday's Opinion | 80% Buy | 8% Sell | 100% Sell | ||
| Last Month's Opinion | 100% Buy | 64% Buy | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +14.29% since 07/31/26 | +9.24% since 07/31/26 | +9.20% since 07/31/26 | ||
| Low | 2.37 on 08/03/26 | 3.51 on 08/03/26 | 4.07 on 08/03/26 | ||
| High | 2.88 on 08/07/26 | 3.97 on 08/04/26 | 4.72 on 08/06/26 | ||
| 1-Month | |||||
| %Chg | -7.28% since 07/07/26 | unch since 07/07/26 | -11.57% since 07/07/26 | ||
| Low | 2.25 on 07/28/26 | 3.35 on 07/28/26 | 4.03 on 07/29/26 | ||
| High | 3.23 on 07/13/26 | 4.02 on 07/09/26 | 5.70 on 07/09/26 | ||
| 3-Month | |||||
| %Chg | +15.23% since 05/07/26 | -4.65% since 05/07/26 | -13.60% since 05/07/26 | ||
| Low | 1.59 on 05/19/26 | 3.28 on 06/05/26 | 3.86 on 06/11/26 | ||
| High | 3.23 on 07/13/26 | 4.59 on 05/08/26 | 6.89 on 05/22/26 | ||
| 6-Month | |||||
| %Chg | +145.61% since 02/06/26 | -6.47% since 02/06/26 | -8.52% since 02/06/26 | ||
| Low | 1.04 on 03/19/26 | 3.28 on 06/05/26 | 3.86 on 06/11/26 | ||
| High | 3.23 on 07/13/26 | 5.15 on 03/12/26 | 6.89 on 05/22/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 290,232 | 294,386 | 288,549 | ||
| Shares Outstanding, K | 116,559 | 76,464 | 64,697 | ||
| Annual Sales, $M | 6,650,000 | 0 | 0 | ||
| Annual Net Income, $M | -136,320,000 | 13,270,000 | -56,020,000 | ||
| Last Qtr Sales, $M | 1,300,000 | 0 | 0 | ||
| Last Qtr Income, $M | -31,210,000 | -18,870,000 | -13,460,000 | ||
| 60-Month Beta | 2.52 | 0.53 | 0.43 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.26 on 05/13/26 | -0.35 on 05/12/26 | -0.21 on 05/15/26 | ||
| Latest Earnings Date | 08/11/26 | 08/06/26 | 11/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||